TrialNutrients2025

Comparison of Rifaximin Monotherapy and Rifaximin Combined with Probiotics in Patients with Irritable Bowel Syndrome: A Randomized Controlled Trial.

Chang Kyo Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.